Kevin/Ross Public Relations has been honored with three awards for creative excellence—including two Gold Awards—from the international MarCom Awards competition, just announced. The agency was cited for excellence while competing against more than 6,500 entries from the United States and several foreign countries.

Kevin/Ross was honored with a prestigious Gold Award for a print advertisement it conceived and wrote on behalf of OneLegacy, the largest organ, eye and tissue recovery organization in the world. The ad featured baseball Hall of Famer and heart transplant recipient Rod Carew and ran in the Los Angeles Dodgers 2019 Yearbook.

A second Gold Award was presented to Kevin/Ross for the extensive television publicity it garnered for the annual “Toys and Joy” celebration at the Orthopaedic Institute for Children in Los Angeles. Held last December, this event attracted nearly 2,000 children and families who watched and shouted in anticipation as Santa Claus helicoptered in with the LAPD SWAT team to deliver holiday cheer and assorted presents to the children.

Kevin/Ross was also honored by MarCom for a commentary it produced on behalf of Dennis Knox, CEO at Mid-Columbia Medical Center in Oregon. The commentary, which appeared in Healthcare Business Today, spoke about the value and importance of partnerships in healthcare as a key to building healthier communities and responding to the consumer wishes for more accessibility, affordability and accountability in their care.

The MarCom Awards is an international creative competition that recognizes outstanding achievement by marketing and communications professionals, both corporate and agency. Over the past eight years, Kevin/Ross has garnered more than two dozen awards from the organization on behalf of a wide range of clients, including (in addition to the three honored this year) SCAN Health Plan, Huntington Memorial Hospital, Loma Linda University Medical Center, Antelope Valley Hospital, MedicareCompareUSA, Clear Vision Information Systems and the California Treatment Advocacy Foundation.